GLP-1 Medications Associated with Rare Vision Loss Risk

A large study has identified a link between GLP-1 medications, including Ozempic and Wegovy, and a rare but potentially permanent form of vision loss. While the overall risk remains low, the findings suggest a need for awareness given the widespread use of these drugs for diabetes and weight management. This information is important for patients and healthcare providers.